Department of Emergency Medicine, University of Cincinnati, Cincinnati, OH 45267-0769, USA.
Prehosp Emerg Care. 2013 Jan-Mar;17(1):1-7. doi: 10.3109/10903127.2012.722177. Epub 2012 Nov 13.
The choice of the optimal benzodiazepine to treat prehospital status epilepticus is unclear. Lorazepam is preferred in the emergency department, but concerns about nonrefrigerated storage limits emergency medical services (EMS) use. Midazolam is increasingly popular, but its heat stability is undocumented.
This study evaluated temperature-dependent degradation of lorazepam and midazolam after 60 days in the EMS environment.
Lorazepam or midazolam samples were collected prior to (n = 139) or after (n = 229) 60 days of EMS deployment during spring-summer months in 14 metropolitan areas across the United States. Medications were stored in study boxes that logged temperature every minute and were stored in EMS units per local agency policy. Mean kinetic temperature (MKT) exposure was derived for each sample. Drug concentrations were determined in a central laboratory by high-performance liquid chromatography. Concentration as a function of MKT was analyzed by linear regression.
Prior to deployment, measured concentrations of both benzodiazepines were 1.0 relative to labeled concentration. After 60 days, midazolam showed no degradation (mean relative concentration 1.00, 95% confidence interval [CI] 1.00-1.00) and was stable across temperature exposures (adjusted R(2) -0.008). Lorazepam experienced little degradation (mean relative concentration 0.99, 95% CI 0.98-0.99), but degradation was correlated to increasing MKT (adjusted R(2) 0.278). The difference between the temperature dependence of degradation of midazolam and lorazepam was statistically significant (T = -5.172, p < 0.001).
Lorazepam experiences small but statistically significant temperature-dependent degradation after 60 days in the EMS environment. Additional study is needed to evaluate whether clinically significant deterioration occurs after 60 days. Midazolam shows no degradation over this duration, even in high-heat conditions.
治疗院前癫痫持续状态的最佳苯二氮䓬类药物选择尚不明确。地西泮在急诊科中更受青睐,但对非冷藏储存的担忧限制了急救医疗服务(EMS)的使用。咪达唑仑的应用日益广泛,但尚未记录其热稳定性。
本研究评估了苯二氮䓬类药物在 EMS 环境中 60 天后温度依赖性降解情况。
在 14 个美国大都市地区的春季-夏季期间,在 EMS 部署前(n = 139)或之后(n = 229)的 60 天内采集地西泮或咪达唑仑样本。药物储存在研究盒中,研究盒每分钟记录一次温度,并按照当地机构的政策储存在 EMS 设备中。为每个样本计算平均动力学温度(MKT)暴露量。在中央实验室通过高效液相色谱法测定药物浓度。通过线性回归分析药物浓度与 MKT 的关系。
在部署之前,两种苯二氮䓬类药物的测量浓度均为标签浓度的 1.0 倍。60 天后,咪达唑仑未发生降解(平均相对浓度 1.00,95%置信区间 [CI] 1.00-1.00),且在各种温度暴露下均稳定(调整后的 R²-0.008)。地西泮的降解程度较小(平均相对浓度 0.99,95% CI 0.98-0.99),但降解与 MKT 呈正相关(调整后的 R²0.278)。咪达唑仑和地西泮降解的温度依赖性差异具有统计学意义(T = -5.172,p < 0.001)。
地西泮在 EMS 环境中 60 天后经历了微小但具有统计学意义的温度依赖性降解。需要进一步研究以评估在 60 天后是否会发生临床显著恶化。在此期间,咪达唑仑未发生降解,即使在高温条件下也未发生降解。